
IMNM
Healthcare · Biotechnology · $2.22B market cap
$18.77+0.07 (+0.4%)Nov 13, 4:00 PM EST
Next report
After the close
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -5.4% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Mar 3, 2027 · upcoming | After the close | -0.64 | — | — |
| Nov 9, 2026 | After the close | -0.67 | -0.76 | -13.4% |
| Aug 11, 2026 | After the close | -0.51 | -0.65 | -27.5% |
| May 7, 2026 | Time not confirmed | -0.59 | -0.48 | +19.5% |
| Mar 3, 2026 | After the close | -0.57 | -0.76 | -33.3% |
| Nov 6, 2025 | After the close | -0.54 | -0.65 | -20.4% |
| Aug 6, 2025 | After the close | -0.50 | -0.50 | 0.0% |
| May 12, 2025 | After the close | -0.57 | -0.52 | +8.8% |
| Mar 19, 2025 | Time not confirmed | -0.68 | -0.84 | -23.5% |
| Nov 13, 2024 | After the close | -0.58 | -0.78 | -34.5% |
| Aug 12, 2024 | After the close | -0.40 | -0.60 | -50.0% |
| May 14, 2024 | Before the open | -0.45 | -2.51 | -457.8% |
| Mar 28, 2024 | After the close | -0.28 |
Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan…
| -4.22 |
| -1407.1% |
| Nov 9, 2023 | Before the open | -0.17 | -0.36 | -111.8% |
| Aug 9, 2023 | Before the open | -0.16 | -0.46 | -187.5% |
| May 5, 2023 | Before the open | 0.59 | -0.35 | -159.3% |
| Mar 16, 2023 | Before the open | -0.67 | -0.64 | +4.5% |
| Nov 14, 2022 | Before the open | -0.78 | -0.75 | +3.8% |
| Aug 5, 2022 | Before the open | -0.93 | -0.74 | +20.4% |
| May 12, 2022 | Before the open | -0.69 | -0.96 | -39.1% |
| Mar 28, 2022 | Before the open | -0.81 | -0.68 | +16.0% |
| Nov 15, 2021 | After the close | -0.50 | -0.65 | -30.0% |
| Aug 16, 2021 | After the close | -0.39 | -0.46 | -17.9% |
| May 12, 2021 | Before the open | -0.41 | -0.37 | +9.8% |
| Mar 25, 2021 | After the close | -0.29 | -0.40 | -37.9% |
| Nov 16, 2020 | After the close | -0.40 | -7.52 | -1780.0% |
| Sep 9, 2020 | Time not confirmed | — | -0.52 | — |